http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190084128-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78941ed5a01bfbcd48376e1fdb485b19 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18fa5d07f044c6e003919232365c4e32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_338652859bd1e57997bfd48fc74a32f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a11c6ee9b6a2ce2b4b815825f6748f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5429284c0f4f7958b2e57ae7473b3cc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e72c201cae51478a5e758fa107aa41c |
| publicationDate | 2019-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190084128-A |
| titleOfInvention | Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| abstract | Aging, or aging-related condition, symptom or disorder; A method of stimulating hair growth, regeneration or pigmentation (or a method of preventing hair loss); A method of increasing the expression of adenosine receptors in dermal cells (with hair growth); Methods for treating a skin condition or disease, or one or more symptoms thereof, including cosmetic treatment (e.g., wrinkles, hyperpigmentation, flushing, injection, drying, gold, loss of firmness, loss of elasticity, skin thinning and loss of life) / RTI > The method comprises administering a sufficient amount of a CBP / catenin (e.g., a CBP / beta -catenin) antagonist as disclosed, and in particular the administration comprises administering to the subject a population of somatic stem cells, In an amount and manner sufficient to increase the number of asymmetric regeneration breaks at the expense. In certain aspects, CBP / catenin (e.g., CBP / beta -catenin) antagonists include the alkyl and / or fatty acid ester derivatives thereof disclosed herein. |
| priorityDate | 2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 827.